Biovail Declares Quarterly Dividend

    TORONTO, August 8 /CNW/ - Biovail Corporation (NYSE:  BVF)(TSX:BVF) today
announced that the Company's Board of Directors has declared a quarterly cash
dividend of US$0.375 per share payable on August 31, 2007, to shareholders of
record at the close of business August 20, 2007.

    Important Income-Tax Information for Canadian Resident Shareholders

    Biovail Corporation designates the entire amount of this taxable dividend
to be an "eligible dividend" for purposes of the Income Tax Act (Canada), as
amended from time to time. This notice meets the requirements of the Income
Tax Act (Canada). Please contact your tax advisor if you have any questions
with regard to the designation of the eligible dividend.

    About Biovail Corporation

    Biovail Corporation is a specialty pharmaceutical company, engaged in the
formulation, clinical testing, registration, manufacture and commercialization
of pharmaceutical products utilizing advanced drug-delivery technologies. For
more information about Biovail, visit the Company's Web site at

    For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to

For further information:

For further information: Biovail Corporation Nelson F. Isabel,
Vice-President, Investor Relations & Corporate Communications, 905-286-3000

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890